Catherine Moncad
Catherine Moncad is Vice President of Regulatory Services at TMC.
TMC is a global clinical research organisation supporting small-to-medium biotech and biopharmaceutical companies through all clinical study stages – from Phase 0 exploratory trials to post-authorisation.
JournalThe importance of patient advocacy in the EMA ODD process
This article discusses the role of patient advocacy groups in the orphan drug designation process to incoporate more patient-centred approaches.